Inhaled interferons beta and SARS-COV2 infection: a preliminary therapeutic perspective.

Elena Cojocaru Cristian Cojocaru Sabina Antonela Antoniu Celina-Silvia Stafie Armand-Gabriel Rajnoveanu Ruxandra Mioara Râjnoveanu

Published in: Expert review of respiratory medicine (2021)

Further clinical studies are needed in order to better document the efficacy of this therapy especially in severe forms of COVID-19, the optimal duration of therapy and if such a medication is appropriate for domiciliary use. Also combined regimens with antivirals or with compounds which are able to enhance the endogenous production of interferon might be of promise.

Keyphrases

coronavirus disease
sars cov
healthcare
cystic fibrosis
respiratory syndrome coronavirus
early onset
emergency department
machine learning
bone marrow
mesenchymal stem cells
artificial intelligence